期刊文献+

奥美拉唑肠溶微丸胶囊的制备及质量考察 被引量:10

Preparation and quality inspection of Omeprazole Enteric-coated Pellets Capsules
下载PDF
导出
摘要 目的制备奥美拉唑肠溶微丸胶囊。方法用离心制丸法直接制备载药母丸,再用流化床包衣法进行微丸包衣;采用正交试验设计对包衣液处方进行筛选优化,研究玉米朊在隔离层上的应用,采用新的肠溶层包衣处方。结果试验处方制得的奥美拉唑肠溶微丸稳定性好,酸性介质中2 h稳定性良好,耐酸力≥98%,p H 6.8缓冲液中释放达标,45 min体外释放度≥90%。结论采用药丸直接起母的方法简化了操作,降低了成本;选用玉米朊作为隔离层成膜材料,很好地提高了奥美拉唑的稳定性;在肠溶层中采用单硬脂酸甘油酯,既促进了微丸的体外释放,又增强了肠溶衣的稳定性。 objective To prepare omeprazole Enteric-coated Pellets Capsules. Methods Female pills of carried drug were directly prepared by centrifugal pill method,then pellets coating was adopted by fluidized bed coating method. The coating solution formulation was optimized by orthogonal design,to study the application of zein in isolation layer,and new enteric-coated prescription was used. Results The prepared omeprazole Enteric-coated Pellets had good stability,and good stability in acidic medium for 2 h. The acid strength≥98%,the release was up to the standard in buffer solution of pH 6. 8,and the vitro release for 45 min≥90%. Conclusion The method was simple and reduced costs. The stability of ome-prazole was raised with zein as the spacer layer forming material. Using glycerol monostearate in the enteric layer,not only promoted the release of the pellets in vitro,but also enhanced the stability of enteric coating.
出处 《药学研究》 CAS 2015年第2期91-94,99,共5页 Journal of Pharmaceutical Research
关键词 奥美拉唑 载药母丸 正交实验 玉米朊 稳定性 单硬脂酸甘油酯 omeprazole Female drug pills orthogonal Zein Stability Glyceryl monostearate
  • 相关文献

参考文献6

二级参考文献64

共引文献73

同被引文献73

  • 1张昆,熊磊,李亶烨,高家菊,刘云宽,马云淑.苍艾油传递体贴剂的制备及其体外评价[J].中国中药杂志,2020,45(4):854-860. 被引量:4
  • 2程盟,邹梅娟,程刚.国产奥美拉唑肠溶胶囊与原研制剂的体外释放度比较[J].中国药剂学杂志(网络版),2014,12(6):193-200. 被引量:5
  • 3吕长淮.药物释放度研究概述[J].安徽医药,2007,11(1):76-78. 被引量:18
  • 4王云明,徐金英,张志明.奥美拉唑肠溶微丸的包衣工艺条件优化[J].中国医药导报,2007,4(08X):102-103. 被引量:5
  • 5Zhikang Ye, Huilin Tang, Jingli Duan, et al. Efficacy and safety of fidaxomicin versus vancomyein for Clostridium diffi- cile infection: systematic review and meta-analysis[J]. J Chin Pharm Sci, 2013, 22 (6) :508-515.
  • 6Fidaxomiein for the Treatment of Clostridium difficile-Associ- ated Diarrhea[D]. FDA Briefing Document for Anti-Infective Drugs Advisory Committee Meeting. April 5, 2011.
  • 7熊贵明,蔡俊安,陈道军.甲基丙烯酸-丙烯酸乙酯共聚物水分散体在阿奇霉素肠溶微丸胶囊中的应用[J].医药前沿,2012,2(12):313.
  • 8ANGIOLILLO D J , GIBSON C M , CHENG S , et al. Differentialeffects of omeprazole and pantoprazole on the pharmacodynamicsand pharmacokinetics of clopidogrel inhealthy subjects:randomized, placebo - controlled,crossovercomparison studies[J] . Clin Pharmacol Ther, 2 0 1 1 ,8 9 ( 1 ) : 6 5 -74.
  • 9SUNG J J,LUO D,WU J C,et al. Early clinical experienceof the safety and effectiveness of Hemospray in achievinghemostasis in patients with acute peptic ulcerbleeding[J] . Endoscopy,2011 ,43(4) :291 -295.
  • 10CHENG E,ZHANG X,HUO X ,t al. Omeprazole blockseotaxin - 3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD [J].Gut,2 0 1 3 , 6 2 ( 6 ) :824 -832.

引证文献10

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部